🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zhiping Ruan

Harvard University

ORCID: 0000-0001-9467-7466

Also affiliated with Massachusetts General Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients”.

Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients

Frontiers in Genetics(2020)10.3389/fgene.2020.00899
N/A
0.396DataRank · unranked
13 citations

Xiao Wang, Jia Hou, Luying Geng, Xuan Liang, Zhiping Ruan +4 more

Liver fibrosis uncouples tumor control from survival after multikinase inhibitor immunotherapy in hepatocellular carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.20.563378
N/A
0.165DataRank · unranked
2 citations

Hiroto Kikuchi, Atsuyo Morita, Tatsuya Kobayashi, Grace Birch, Zhiping Ruan +14 more

Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.26.525680
N/A
0.165DataRank · unranked
2 citations

Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Zelong Liu, Sarah M. Shin +17 more

Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac051
N/A
0DataRank · unranked
73 citations

Aya Matsui, Satoru Morita, Zohreh Amoozgar, Koetsu Inoue, Zhiping Ruan +7 more

Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy

Nature Communications(2022)10.1038/s41467-022-28279-8
N/A
0DataRank · unranked
261 citations

Jiang Chen, Hui Zhou, Xiaodong Zeng, Zhiping Ruan, Zhangya Pu +9 more

Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-0486
N/A
0DataRank · unranked
28 citations

Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Zelong Liu, Sarah M. Shin +20 more

A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy

ACS Pharmacology & Translational Science(2024)10.1021/acsptsci.4c00358
N/A
0DataRank · unranked
5 citations

Subhasish Tapadar, Zhiping Ruan, Carrie Sun, Rebecca S. Arnold, Alexis Johnston +8 more

A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.27.587062
N/A
0DataRank · unranked
1 citations

Subhasish Tapadar, Zhiping Ruan, Carrie Sun, Rebecca S. Arnold, Alexis Johnston +8 more

Inflammasome targeting with an NLRP3 agonist therapy is feasible but ineffective in murine hepatocellular carcinoma models with liver damage

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.23.497362
N/A
0DataRank · unranked
0 citations

Zelong Liu, Chen Jiang, Koetsu Inoue, Zhiping Ruan, Lingling Zhu +5 more